Life Science Compliance Update



Fresenius to the U.S. Government: When It Comes to the FCA, You Snooze You Lose

Written by , Posted in False claims

Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update

In a nearly decade long lawsuit allegations that the company violated the False Claims Act by conducting and then billing the government for medically unnecessary hepatitis B tests, Fresenius is now seeking to challenge that the government is time-barred because the government took too long to intervene in this case. Although the Court has yet to decide the challenge by Fresenius, the outcome of that decision will likely have a significant impact on future government decisions to intervene in False Claim Act cases.


Topic tags:

Menu Title